The literature on the treatment of MC with HP is limited to an open study on 12 immunocompetent children who were treated with HP 1% cream applied twice daily for 21 days. In eight patients (67%), complete remission of MC lesions was observed, and in the remaining four patients, a reduction of 70% in the number of the lesions was recorded. No recurrence was observed over an average follow-up period of 6 months.5 Furthermore, an 8-month-old girl with multiple MC lesions on the genital area was successfully treated with the same cream under occlusion.2 To our knowledge, no controlled clinical studies have been published.Our study, based on a rather small number of patients, but on a high number of lesions, shows that HP 1.8% gel, applied twice daily under occlusion for 3 weeks, is a potential treatment of immunocompetent children with multiple MC. However, a higher number of patients and lesions is necessary for definitive conclusions.